Literature DB >> 6603807

An immunologic evaluation of hemophiliac patients and their wives. Relationships to the acquired immunodeficiency syndrome.

R D deShazo, W A Andes, J Nordberg, J Newton, C Daul, B Bozelka.   

Abstract

Recently, hemophiliac patients receiving factor VIII concentrate therapy have developed the acquired immunodeficiency syndrome. Because abnormalities of cell-mediated immunity are found in this syndrome, we evaluated the peripheral blood immunologic status of 24 patients with classic hemophilia and 5 patients with factor IX deficiency. Both groups had decreased percentages and numbers of helper-inducer lymphocytes (OKT4+) and increased percentages of suppressor-cytotoxic T-lymphocytes (OKT8+) which resulted in depressed OKT4/T8 ratios. Abnormalities of the T-lymphocyte subpopulation were most severe in 7 patients with factor VIII deficiency with lymphadenopathy who also had increased Ia+ cells and profoundly suppressed lymphocyte mitogenic responses. No correlation was found between OKT4/OKT8 ratios or lymphocyte responses to mitogen and the amount of factor VIII concentrate used per year. Evaluation of five wives of factor-VIII-deficient patients who had abnormal OKT4/OKT8 ratios showed decreased percentages of OKT4 cells, but normal lymphocyte mitogenic responses. Serum levels of IgG were elevated in factor-VIII-deficient patients but not their wives or factor-IX-deficient patients. We conclude that T-lymphocyte subpopulation abnormalities and lymphocyte mitogenic responses are depressed in asymptomatic hemophiliac patients receiving either factor VIII or factor IX concentrates. These abnormalities are most severe in otherwise asymptomatic hemophiliac patients who have developed lymphadenopathy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603807     DOI: 10.7326/0003-4819-99-2-159

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.

Authors:  B T Shannon; J Roach; M Cheek-Luten; C Orosz; F B Ruymann
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

2.  Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.

Authors:  J A Brieva; J Sequi; J M Zabay; A Pardo; A Campos; M Luz de la Sen; A Bootello
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

3.  Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III).

Authors:  C R Horsburgh; K C Davis; U Hasiba; S H Weiss; J J Goedert; P Sarin; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

4.  Heterosexual transmission of HIV in hemophiliacs.

Authors:  T Kamradt; D Niese; H H Brackmann; K E Schneweis; B Kamps; B van Loo; P Euler
Journal:  Klin Wochenschr       Date:  1990-12-17

5.  Lymphocyte subset ratios and factor VIII usage in haemophilia.

Authors:  A C Beddall; K Al-Rubei; M D Williams; F G Hill
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

6.  Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation-linked cell-surface antigens.

Authors:  U Köller; O Majdic; K Liszka; H Stockinger; I Pabinger-Fasching; K Lechner; W Knapp
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

Review 7.  The retinal lesions of the acquired immune deficiency syndrome.

Authors:  A H Friedman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

8.  T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection.

Authors:  J E Morgan; C B Daul; R D de Shazo; W A Andes; N H Hyslop
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

9.  HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs.

Authors:  M V Ragni; P Gupta; C R Rinaldo; L A Kingsley; J A Spero; J H Lewis
Journal:  Public Health Rep       Date:  1988 Jan-Feb       Impact factor: 2.792

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.